About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Researchers Identify Potential Target for Anti-craving Medications

by Sheela Philomena on January 27, 2012 at 11:46 AM
Font : A-A+

 Researchers Identify Potential Target for Anti-craving Medications

A new target for the development of anti-carving medications for people with addictive behaviors has been identified by researchers.

The new discovery by the Scientists at the Centre for Addiction and Mental Health (CAMH) centres on a brain receptor related to the chemical dopamine, which has a complex role in addictive behaviours.

Advertisement

Using brain scans and a novel chemical probe developed in CAMH's Research Imaging Centre, CAMH scientists found that the probe had high levels of binding to the dopamine D3 receptor in some people with methamphetamine addiction, compared with those who had no addiction.

Higher levels of D3 were also linked to participants' reported motivation to take drugs.

"This is the first time, to our knowledge, that anyone has shown that D3 receptor levels are high in people with an active addiction to methamphetamine," said Dr. Isabelle Boileau, a scientist in the Research Imaging Centre, part of the new Campbell Family Research Institute at CAMH, who led the study.
Advertisement

Using positron emission tomography (PET), Boileau's team looked at D3 levels in 16 people who were dependent on methamphetamine. Participants abstained from methamphetamine use for 14 days prior to brain scans.

Their results were compared with scans from 16 participants with no addiction. On a separate day after scanning, participants were given a low dose of amphetamine, and they had to report how much they wanted to use drugs.

D3 receptors appear to have a role in craving, but it is not fully established how they are related to drug-related behaviours.

The new chemical probe developed at CAMH, called 11C-(+)-PHNO, binds to dopamine D3 receptors. This probe allows researchers to study D3 in people for the first time, using PET scans, in order to answer questions about its role in stimulant addiction.

Understanding the role of brain receptors in addiction has enabled researchers to develop treatment medications, such as nicotine replacement therapy for smoking. So far, therapeutic strategies for stimulant addiction have focused on increasing activity with D2 receptors, where binding levels have been low.

"We can now suggest that any therapeutic approach aimed at increasing activity with D2 receptors should consider being selective at targeting D2, and not increasing D3 levels. Our finding also supports the idea that D3 should be considered another target for anti-craving medications," said Boileau.

The study has been recently published in The Journal of Neuroscience.

Source: ANI
Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Alcohol & Drug Abuse News

 Quit Smoking Fast With Treatment Clearing Nicotine Metabolism Disparities
A new study analyses Whether treatment support can optimize nicotine replacement therapy to quit smoking faster, using biomarker nicotine metabolite ratio.
How Genetic Risk Information Can Help People Avoid Alcohol Addiction?
The genetic risk scores developed was found to be helpful in preventing and treating alcohol addiction.
New Jersey Medicaid Reforms: A Path to Recovery from Opioid Addiction
The percentage of caregivers prescribing buprenorphine increased faster after the Medicaid reforms implementation.
 Heavy Alcohol Drinking Put 1 In 3 Americans at Risk for Metabolic Syndrome
New study examined whether metabolic syndrome could be a reason for increased mortality from alcohol-associated liver disease (ALD) despite declining alcohol use.
Stimulants are Making a Comeback: The Rise of Cocaine Abuse
Addiction scientists try to decode cocaine use disorder.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Researchers Identify Potential Target for Anti-craving Medications Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests